SavedAdd your journal

Journals / Dicle Tıp Dergisi / 2026 / Cilt: 42 Sayı: 2

-

İntravezikal BCG immunoterapisini takiben gelişen Reiter sendromu: Olgu sunumu

Fatih Elbir
Ramazan Topaktaş
İsmail Başıbüyük
Abdullah Armağan
Pages
—
Publication Date
2015-07-09
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

We report here the case of Reiter’s Syndrome following BCG instillation with a different clinical manifestation

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Intravesical instillation of Bacillus Calmette Guerin (BCG) is used in the treatment of patients with superficial bladder carcinoma with efficacy and safety.
📊
Key Findings & Data:Although clinically very effective this method is associated with a variety of side effects.
💡
Conclusion & Impact:We report here the case of Reiter’s Syndrome following BCG instillation with a different clinical manifestation
🔬Design:Makale
📍Scope:Comprehensive Sample
⚙️Variables:İnvaziv olmayan mesane tümörü · int · Non-invasive bladder carcinoma

Abstract

Intravesical instillation of Bacillus Calmette Guerin (BCG) is used in the treatment of patients with superficial bladder carcinoma with efficacy and safety. Although clinically very effective this method is associated with a variety of side effects. In these side effects, Reiter’s Syndrome is occurred most rare. We report here the case of Reiter’s Syndrome following BCG instillation with a different clinical manifestation

Özet

Intravesical instillation of Bacillus Calmette Guerin (BCG) is used in the treatment of patients with superficial bladder carcinoma with efficacy and safety. Although clinically very effective this method is associated with a variety of side effects. In these side effects, Reiter’s Syndrome is occurred most rare. We report here the case of Reiter’s Syndrome following BCG instillation with a different clinical manifestation. Key words: Non-invasive bladder carcinoma, intravesical instillation of Bacillus Calmette Guerin (BCG), Reiter’s syndrome

🔖

Cite This Article

Elbir, F., Topaktaş, R., Başıbüyük, İ., Armağan, A. (2015). -. Dicle Tıp Dergisi, Cilt: 42 Sayı: 2. https://doi.org/10.5798/diclemedj.0921.2015.02.0569

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Lamm DL, Stogdill VD, Stogdil BJ, Crispen RG. Complications of Bacillus Calmette-Guerin immunotherapy in 1278 patients with bladder cancer. J Urol 1986;135:272-274.
  2. Odom RB, Jome WD, Berger TG. Andrews’ diseases of the
  3. skin. 9th ed. United States of America: WB Saunders Company; 2000.
  4. Parker CT, Thomas D. Reiter’s syndrome and reactive arthritis. J Am Osteopath Assoc 2000;100:101-104.
  5. Graham RB, Champion RH, Burton JL. Reiter’s disease, Ebling FJG Textbook of Dermatology. 5th ed. Turin: Blackwell scientific publications; 1992.
  6. Lamm DL, Van Der Mejden ADPM, Morales A, et al. Incidence and treatment of Bacillus Calmette-Guerin intravesical therapy in superficial bladder cancer. J Urol 1992;147:596-600.
  7. Kodali VR, Clauge RB. Arthritis after BCG vaccine in a
  8. healthy woman. J Intern Med 1998; 244:183-184.
  9. Pancaldi P, Van Linthoudt D, Alborino D, et al. Reiter’s Syndrome after intravesical Bacillus Calmette-Guerin treatment for superficial bladder carcinoma. Br J Rheumatol;32:1096-1098.
  10. Wu IB, Schwartz RA. Reiter’s syndrome: the classic triad
  11. and more. J Am Acad Dermatol 2008;59:113-121.
  12. Ng KL, Chua CB. Reiter’s syndrome post intravesical Bacillus Calmette-Guerin instillations. Asian J Surg 2014, http://
  13. dx.doi.org/10.1016/j.asjsur.2014.01.016